Read more
Zusatztext In the vast field of the publications on hepatitis C, a book like this is sorely needed. The authors have succeeded in writing a meaningful, user-friendly guide to hepatitis C... The book covers may subjects, from basic virology, epidemiology, and diagnostic testing to treatment and dealing with side effects of the antiviral drugs. The information is condensed but well organized, so readers are not overwhelmed. Informationen zum Autor Donald Jensen is the Director of the Center for Liver Disease, and is a Professor of Medicine at the University of Chicago Medical Center, Chicago, ILNancy Reau is an Associate Professor of Medicine at the Center for Liver Disease, University of Chicago Medical Center, Chicago, IL Klappentext Hepatitis C is a practical, evidence-based handbook that provides a comprehensive overview of the disease. It is an ideal resource for clinicians directly involved in the care of patients with hepatitis C. Zusammenfassung Rapid and profound changes are taking place in the field of hepatitis C therapeutics. More than ever, these changes necessitate a current, clinically pertinent review of the broader scope of hepatitis C, including its epidemiology, diagnosis, natural history, and clinical features. This handbook provides that concise survey of the field. Acute and chronic hepatitis C are addressed as are important new treatment options for hepatitis C, management of side effects, and a convenient summary of clinical trials on the treatment of chronic hepatitis C. Part of the Oxford American Infectious Disease Library, this evidence-based clinical resource will appeal to clinicians directly involved in the care of patients with hepatitis C. Inhaltsverzeichnis 1. Basic Virology 2. Epidemiology of Hepatitis 3. Natural History of Hepatitis 4. Diagnostic Testing 5. Pathology of Viral Hepatitis 6. Acute Hepatitis 7. Chronic Hepatitis 8. Extrahepatic Manifestations of Hepatitis 9. Hepatitis C in Liver Transplantation 10. Treatment of Hepatitis 11. Side Effect Management of Peginterferon and Ribavirin 12. Hepatitis C in Special Populations 13. New Treatments: Telaprevir and Boceprevir 14. HCV Directly Acting Antiviral Therapies (Other than Boceprevir and Telaprevir) 15. Lexicon of Trials for Treatment of Chronic Hepatitis C Appendix 197 ...
